DAUNORUBICIN/CYTARABINE LIPOSOME - INJECTION
PHONETIC PRONUNCIATION: (DAW-noe-ROO-bi-sin/sye-TAR-abeen)
COMMON BRAND NAME(S): Vyxeos
GENERIC NAME(S): daunorubicin/cytarabine liposomal
Uses
USES: This medication is a combination product of daunorubicin and cytarabine liposome and is used to treat leukemia. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
How to use DAUNORUBICIN/CYTARABINE LIPOSOME - INJECTION
HOW TO USE: This medication is given by injection into a vein as directed by your doctor. It is given by a health care professional, usually over 90 minutes. The dosage and treatment schedule are based on your medical condition, body size, and response to treatment. Drink plenty of fluids while using this medication unless otherwise directed by your doctor. Doing so helps decrease the risk of certain side effects (such as increased uric acid).
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for DAUNORUBICIN/CYTARABINE LIPOSOME - INJECTION
Daunorubicin/Cytarabine Liposome - Injection is used to treat certain types of aggressive and recurrent acute myeloid leukemia (AML) in adults.
It combines two chemotherapy drugs, daunorubicin and cytarabine, encapsulated in liposomes. These liposomes help to deliver the drugs directly to cancer cells, increasing their effectiveness in killing the cancer cells.
Common side effects may include nausea, vomiting, diarrhea, mouth sores, hair loss, fatigue, fever, and a decreased number of blood cells.
It is typically administered by a healthcare professional through intravenous infusion over a period of about 90 minutes.
The treatment schedule is usually determined by your healthcare provider based on your specific condition. It is typically given for several days in a row, with cycles repeated every few weeks.
Yes, this medication may cause serious or potentially life-threatening heart problems. It may also increase the risk of infections and bleeding. It is important to discuss your medical history and any current medications with your healthcare provider before starting this treatment.
It is important to inform your healthcare provider about all the medications, supplements, and herbal products you are taking before starting this treatment. Some medications may interact with Daunorubicin/Cytarabine Liposome - Injection and affect its effectiveness or increase the risk of side effects.
It is not recommended to use this medication during pregnancy as it may harm the unborn baby. It is also not recommended while breastfeeding. It is important to discuss the potential risks and benefits with your healthcare provider.
The medication should be stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F), and it should be protected from light. It should not be frozen.
Warning
WARNING: This medication is not given the same way as similar products including daunorubicin, daunorubicin liposome, cytarabine, or cytarabine liposome. Do not use any of these similar products while using daunorubicin/cytarabine liposome injection. This medication may rarely cause serious (rarely fatal) heart problems (including heart failure). This effect may occur during treatment or months to years after treatment is completed. The risk of heart problems is increased if you have heart disease, or have had radiation treatment to the chest area, or use/have used drugs that can also cause heart problems. Tell your doctor right away if you notice symptoms such as irregular heartbeat, shortness of breath, swelling ankles/feet, unusual tiredness, or unusual/sudden weight gain. This medication decreases bone marrow function, an effect that may lead to a low number of blood cells such as red cells, white cells, and platelets. This effect can cause anemia, decrease your body's ability to fight an infection, or cause easy bruising/bleeding. Tell your doctor right away if you develop any of the following symptoms: unusual tiredness, pale skin, signs of infection (such as sore throat that doesn't go away, fever, chills), easy bruising/bleeding. This medication must be given only by injection into a vein. It must not be given by injection into a muscle or under the skin. If this medication accidentally leaks into the skin/muscle around the injection site, it may cause severe damage. Tell your doctor right away if you notice redness, pain, or swelling at or near the injection site.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet